Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on May 30, 2025
LosAngelesMedicalMalpracticeLawyers.com Launches to Connect Individuals with Malpractice Lawyers
EIN Presswire
·
May 30, 2025
LOS ANGELES, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- A new website, losangelesmedicalmalpracticelawyers.com, has been launched to assist individuals in the Los Angeles area in finding the best medical malpractice lawyer for their case. The …
Diagnostic BioSystems Inc. receives SFDA approval for its extensive IHC Product portfolio
EIN Presswire
·
May 30, 2025
Diagnostic BioSystems Inc. USA announces the approval for its Extensive portfolio of IHC products by the Saudi Food and Drug Authority (SFDA) PLEASANTON, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Diagnostic BioSystems Inc. (DBS), a pioneer …
Stanton Optical Expands Reach with New Store in Bakersfield, CA
EIN Presswire
·
May 30, 2025
Full-Service Eye Care, Offering Hi-tech Eye Exams, Eye Health Solutions and Affordable Eyewear BAKERSFIELD, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Stanton Optical, a pioneer in affordable and accessible eye care, announces the grand …
HYCOR Awarded Allergy Testing Product and Service Agreement with Premier, Inc.
EIN Presswire
·
May 30, 2025
Access to Premier’s healthcare group purchasing organization (GPO) is expected to expand national market reach for HYCOR’s allergy diagnostic solutions. GARDEN GROVE, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- HYCOR Biomedical LLC has been …
Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals
GlobeNewswire
·
May 30, 2025
“It was an outstanding quarter. We exceeded our Q1 projections with approximately 34% YOY growth from our first two verticals, a clear sign that our strategy is working. We also secured new customers for VSDHOne, positioning us strongly to hit our year-end …
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
GlobeNewswire
·
May 30, 2025
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced that he has filed an early warning report (the "Early Warning Report") under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider …
Celularity Receives Nasdaq Notice Regarding Form 10-Q
GlobeNewswire
·
May 30, 2025
FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that on May 28, 2025, Nasdaq notified the Company that it did not timely file …
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
GlobeNewswire
·
May 30, 2025
Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution Agreement”) with Goodwood Inc., Goodwood …
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
GlobeNewswire
·
May 30, 2025
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to …
Cornerstone of Southern California Treatment Center Announces New Ownership and Vision for the Future of Recovery Care
EIN Presswire
·
May 30, 2025
Cornerstone of Southern California is under new ownership and will continue providing transformational and life-changing substance use disorder treatment. SANTA ANA, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Cornerstone of Southern …
Publication relating to transparency notifications
GlobeNewswire
·
May 30, 2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 30, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …
Publication relative à des notifications de transparence
GlobeNewswire
·
May 30, 2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 30 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations …
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
GlobeNewswire
·
May 30, 2025
Company continues to progress both REYOBIQ™ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage …
NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association
GlobeNewswire
·
May 30, 2025
TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that Professor Nahshon Knoller M.D., senior clinical advisor to the Company, will …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 30, 2025
VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025
GlobeNewswire
·
May 30, 2025
WATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will announce results from …
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
GlobeNewswire
·
May 30, 2025
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integrate …
America’s Blood Centers and ACS Stop the Bleed Announce New National Collaboration
GlobeNewswire
·
May 30, 2025
Washington, DC, May 30, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, and the American College of Surgeons (ACS) Stop the …
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
GlobeNewswire
·
May 30, 2025
MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity …
PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid’s D-PLEX100 Approaches Critical Phase 3 Data Readout
GlobeNewswire
·
May 30, 2025
New York, May 30, 2025 (GLOBE NEWSWIRE) -- PESG Research is releasing a report today examining PolyPid Ltd.*, an innovative late-stage biopharmaceutical company developing revolutionary localized drug delivery technologies for surgical infection …